Colorectal cancer prevention in the Czech Republic: Time trends in performance indicators and current situation after 10 years of screening

European Journal of Cancer Prevention

Volumn 23, Issue 1, 2014, Pages 18-26

  Suchanek, Stepan ^a,b   Majek, Ondrej ^e   Vojtechova, Gabriela ^a   Minarikova, Petra ^a   Rotnaglova, Barbora ^a   Seifert, Bohumil ^b   Minarik, Marek ^c   Kozeny, Pavel ^d   Dusek, Ladislav ^e   Zavoral, Miroslav ^a  

^a Department of Medicine   (Japan)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Genomac Research Institute   (Czech Republic)

^d National Reference Centre   (Czech Republic)

^e MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Colonoscopy; Colorectal cancer; Czech Republic; Fecal occult blood test; Screening

Indexed keywords

INDICATOR;

ADENOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CZECH REPUBLIC; FEMALE; FOLLOW UP; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PERFORMANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING;

COLONOSCOPY; COLORECTAL NEOPLASMS; CZECH REPUBLIC; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; SURVIVAL RATE; TIME FACTORS;

EID: 84889250860     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328364f203     Document Type: Article

References (26)

1. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. UK Flexible Sigmoidoscopy Trial Investigators (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomized controlled trial. Lancet 375:1624-1633.
2. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L (2011). Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 140:65-72.
3. Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al. (2012). Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer 130:2961-2973.
4. Brenner H, Gefeller O, Hakulinen T (2004). Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 40:326-335. (Pubitemid 38121268)
5. Corazziari I, Quinn M, Capocaccia R (2004). Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40:2307-2316. (Pubitemid 39348882)
6. Dusek L, Muzik J, Kubásek M, Koptikova J, Zaloudik J, Vyzula R (2007.). Epidemiology of malignant tumors in the Czech Republic Version 7.0, ISSN 1802-8861. Czech Republic: Masaryk University 2007. Available at: http://www.svod.cz [Accessed 30 October 2011].
7. Ederer F, Axtell LM, Cutler SJ (1961). The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101-121.
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010.). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon: International Agency for Research on Cancer 2010. Available at: http://globocan.iarc.fr [Accessed 30 November 2012].
9. Hakulinen T (1982). Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38:933-942.
10. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol 103:1541-1549. (Pubitemid 351813919)
11. Human Mortality Database. University of California, Berkeley, USA, and Max Planck Institute for Demographic Research, Germany. Available at: http://www.mortality.org/Public/CitationGuidelines.php [Accessed 3 July 2012].
12. Hundt S, Haug U, Brenner H (2009). Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150:162-169.
13. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. (2010). Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362:1795-1803.
14. Karsa LV, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. (2008). Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening - First report. ISBN 978-92- 79-08934-3. Luxembourg: European Communities, by the services of the European Commission.
15. Moss S, Ancelle-Park R, Brenner H (2010). Evaluation and interpretation of screening outcomes. In: Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: Publications Office of the European Union. pp. 72-102.
16. Panteris V, Haringsma E, Kuipers EJ (2009). Colonoscopy perforation rate, mechanism and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy 41:941-951.
17. Pox CP, Altenhofen L, Brenner H, Theilmeier A, Stillfried DV, Schmiegel W (2012). Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 142:1460-1467.
18. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. (2012). Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345-2357.
19. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. (2011). Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 103:1310-1322.
20. Sieg A, Friedrich K (2009). Perspectives of colorectal cancer screening in Germany 2009. World J Gastrointest Endosc 1:12-16.
21. Sobin LH, Gospodarowicz MK, Wittekind Ch (2009). TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell.
22. Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. (2012). Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 61:576-581.
23. World Health Organization (1992). International statistical classification of diseases and related health problems, 10th revision (ICD-10). Geneva: World Health Organization.
24. World Health Organization (2010). WHO Statistical Information System. Geneva, Switzerland: WHO Databank 2010. Available at: http://www.who.int/whosis [Accessed 4 September 2010].
25. Zastera J, Roewer L, Willuweit S, Sekerka P, Benesova L, Minarik M (2010). Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructure. Forensic Sci Int Genet 4 (Issue 3):e75-e78.
26. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. (2009). Colorectal cancer screening in Europe. World J Gastroenterol 47:5907-5915.